Trials / Completed
CompletedNCT01569906
Narrowband UVB for Children With Moderate to Severe Atopic Eczema
Narrowband Ultraviolet B Phototherapy in Children With Moderate to Severe Atopic Eczema- an Observational Prospective Controlled Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Royal Victoria Infirmary · Academic / Other
- Sex
- All
- Age
- 3 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
To assess prospectively, the response of moderate to severe atopic eczema to a standard course of narrowband ultraviolet B phototherapy by using validated objective and subjective scoring systems.
Detailed description
Children with moderate to severe atopic eczema prescribed a course of narrowband UVB phototherapy were scored (using validated scoring systems) objectively and subjectively before, during and after the course of treatment, as well as 3 and 6 months post treatment (to determine length of remission). Their scores were compared to a control group. The control group comprised children with moderate to severe atopic eczema who were offered UVB but were unable to undertake the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Narrowband Ultraviolet B phototherapy | Twice weekly exposures for a total of 24 exposures using a standard phototherapy protocol. |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2012-04-03
- Last updated
- 2012-04-05
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01569906. Inclusion in this directory is not an endorsement.